Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorne Gula

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 29, 2021
Comparative effectiveness of ventricular tachycardia ablation vs. escalated antiarrhythmic drug therapy by location of myocardial infarction: a sub-study of the VANISH trialMichelle Samuel, Lena Rivard, Isabelle Nault, et al.
Heart Rhythm|December 17, 2017
Relative timing of near-field and far-field electrograms can determine the tachyarrhythmia site of originJane Caldwell, Lorne Gula, Fariha Sadiq Ali, et al.
JACC. Clinical Electrophysiology|July 21, 2018
Prognostic Value of Noninducibility on Outcomes of Ventricular Tachycardia Ablation: A VANISH SubstudyVidal Essebag, Jacqueline Joza, Pablo B Nery, et al.
Circulation. Cardiovascular Imaging|November 1, 2011
Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmiasJames A White, Nowell M Fine, Lorne Gula, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 14, 2022
Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trialMarc W Deyell, Steve Doucette, Ratika Parkash, et al.
Journal of Cardiovascular Electrophysiology|July 27, 2020
Treatment with corticosteroids is associated with an increase in ventricular arrhythmia burden in patients with clinically manifest cardiac sarcoidosis: Insights from implantable cardioverter-defibrillator diagnosticsMaria C Medor, Stewart Spence, Pablo B Nery, et al.
Circulation. Arrhythmia and Electrophysiology|October 22, 2009
A randomized controlled trial of the efficacy and safety of electroanatomic circumferential pulmonary vein ablation supplemented by ablation of complex fractionated atrial electrograms versus potential-guided pulmonary vein antrum isolation guided by intracardiac ultrasoundYaariv Khaykin, Allan Skanes, Jean Champagne, et al.
Circulation. Arrhythmia and Electrophysiology|January 7, 2018
Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease)Ratika Parkash, Isabelle Nault, Lena Rivard, et al.
Circulation. Cardiovascular Imaging|May 11, 2012
Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imagingPeng Gao, Raymond Yee, Lorne Gula, et al.
Circulation|February 24, 2017
Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])Ratika Parkash, George A Wells, John L Sapp, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 29, 2021
Comparative effectiveness of ventricular tachycardia ablation vs. escalated antiarrhythmic drug therapy by location of myocardial infarction: a sub-study of the VANISH trialMichelle Samuel, Lena Rivard, Isabelle Nault, et al.
Heart Rhythm|December 17, 2017
Relative timing of near-field and far-field electrograms can determine the tachyarrhythmia site of originJane Caldwell, Lorne Gula, Fariha Sadiq Ali, et al.
JACC. Clinical Electrophysiology|July 21, 2018
Prognostic Value of Noninducibility on Outcomes of Ventricular Tachycardia Ablation: A VANISH SubstudyVidal Essebag, Jacqueline Joza, Pablo B Nery, et al.
Circulation. Cardiovascular Imaging|November 1, 2011
Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmiasJames A White, Nowell M Fine, Lorne Gula, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 14, 2022
Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trialMarc W Deyell, Steve Doucette, Ratika Parkash, et al.
Journal of Cardiovascular Electrophysiology|July 27, 2020
Treatment with corticosteroids is associated with an increase in ventricular arrhythmia burden in patients with clinically manifest cardiac sarcoidosis: Insights from implantable cardioverter-defibrillator diagnosticsMaria C Medor, Stewart Spence, Pablo B Nery, et al.
Circulation. Arrhythmia and Electrophysiology|October 22, 2009
A randomized controlled trial of the efficacy and safety of electroanatomic circumferential pulmonary vein ablation supplemented by ablation of complex fractionated atrial electrograms versus potential-guided pulmonary vein antrum isolation guided by intracardiac ultrasoundYaariv Khaykin, Allan Skanes, Jean Champagne, et al.
Circulation. Arrhythmia and Electrophysiology|January 7, 2018
Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease)Ratika Parkash, Isabelle Nault, Lena Rivard, et al.
Circulation. Cardiovascular Imaging|May 11, 2012
Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imagingPeng Gao, Raymond Yee, Lorne Gula, et al.
Circulation|February 24, 2017
Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])Ratika Parkash, George A Wells, John L Sapp, et al.
Pageof 3